B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Osi 930

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Osi 930, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rivoceranib
3 shared targets
selpercatinib
2 shared targets
cep
7 shared targets
regorafenib
6 shared targets
vatalanib
4 shared targets
gw559768x
2 shared targets
pexidartinib
3 shared targets
Avapritinib
2 shared targets · score 43.1
semaxanib
3 shared targets
su
2 shared targets
Loading evidence profile...

This evidence profile for Osi 930 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.